These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8921770)

  • 21. The physiology of lipoproteins.
    Tulenko TN; Sumner AE
    J Nucl Cardiol; 2002; 9(6):638-49. PubMed ID: 12466789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoproteins and atherogenesis. Current concepts.
    Steinberg D; Witztum JL
    JAMA; 1990 Dec; 264(23):3047-52. PubMed ID: 2243434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An apheresis method in treatment of familial hypercholesterolemia].
    Derfler K
    Wien Klin Wochenschr; 2000 Jan; 112(2):49-51. PubMed ID: 10703150
    [No Abstract]   [Full Text] [Related]  

  • 24. Lipoprotein(a). A unique risk factor for atherothrombotic disease.
    Loscalzo J
    Arteriosclerosis; 1990; 10(5):672-9. PubMed ID: 2144959
    [No Abstract]   [Full Text] [Related]  

  • 25. The lipoprotein fraction between VLDL and LDL detected by biphasic agarose gel electrophoresis reflects serum remnant lipoprotein and Lp(a) concentrations.
    Sato I; Taniguchi T; Ishikawa Y; Kusuki M; Hayashi F; Mukai M; Kawano S; Kondo S; Yamashita S; Kumagai S
    J Atheroscler Thromb; 2006 Feb; 13(1):55-61. PubMed ID: 16505592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men.
    Svensson J; Bengtsson BA; Taskinen MR; Wiklund O; Johannsson G
    Growth Horm IGF Res; 2000 Jun; 10(3):118-26. PubMed ID: 10942632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein(a) further invalidates Friedewald formula.
    Scanu AM
    Clin Chem; 1994 Nov; 40(11 Pt 1):2115. PubMed ID: 7955393
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dyslipoproteinemia as a coronary risk factor].
    Yamamura T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():738-45. PubMed ID: 12735059
    [No Abstract]   [Full Text] [Related]  

  • 29. Low-density lipoprotein cholesterol bulk is the pivotal determinant of atherosclerosis in familial hypercholesterolemia.
    Raal FJ; Pilcher GJ; Waisberg R; Buthelezi EP; Veller MG; Joffe BI
    Am J Cardiol; 1999 May; 83(9):1330-3. PubMed ID: 10235090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein composition and serum Lp(a) lipoprotein in hypobetalipoproteinaemia.
    Crook M; Swaminathan R
    J Clin Pathol; 1995 Jun; 48(6):587-9. PubMed ID: 7665710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Postmenopausal estrogen replacement therapy and the risk of atherosclerotic cardiovascular diseases].
    Donders SH
    Ned Tijdschr Geneeskd; 1992 Jul; 136(30):1478. PubMed ID: 1436167
    [No Abstract]   [Full Text] [Related]  

  • 32. Disparate effects of interleukin-3 on serum lipoprotein(a), and low- and high-density lipoprotein cholesterol levels.
    Hansen PR; Hovgaard D
    Am J Cardiol; 1995 Feb; 75(4):296-7. PubMed ID: 7832146
    [No Abstract]   [Full Text] [Related]  

  • 33. Beyond low-density lipoprotein cholesterol. A perspective on low high-density lipoprotein disorders and Lp(a) lipoprotein excess.
    Rosenson RS
    Arch Intern Med; 1996 Jun; 156(12):1278-84. PubMed ID: 8651835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Atherosclerosis and blood lipoproteins].
    Faergeman O
    Ugeskr Laeger; 2001 May; 163(21):2924-6. PubMed ID: 11402971
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-Density Lipoprotein Measurement Discordance: When 2 Wrongs Lead to the Right Answer-Elevated Lipoprotein (a).
    Intwala S; Stone NJ; Balady GJ
    JAMA Cardiol; 2017 Jun; 2(6):697-698. PubMed ID: 28355452
    [No Abstract]   [Full Text] [Related]  

  • 37. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
    Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
    G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein(a) Mass Levels Increase Significantly According to
    Moriarty PM; Varvel SA; Gordts PL; McConnell JP; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):580-588. PubMed ID: 28062489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which cholesterol are we measuring with the Roche direct, homogeneous LDL-C Plus assay?
    Ordóñez-Llanos J; Wägner AM; Bonet-Marqués R; Sánchez-Quesada JL; Blanco-Vaca F; González-Sastre F
    Clin Chem; 2001 Jan; 47(1):124-6. PubMed ID: 11148187
    [No Abstract]   [Full Text] [Related]  

  • 40. [Risk factors of arteriosclerosis. Differential profile--various mechanisms?].
    Seidel D
    Z Kardiol; 1993; 82 Suppl 5():33-7. PubMed ID: 8154160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.